venous thrombosis
Conditions
Interventions
Sponsors
Sichuan Cancer Hospital & Institute Sichuan Cancer Center School of Medicine University of Electronic Science and Technology of China
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1)Diagnosed with COPD in the past, admitted to the hospital due to acute exacerbation of COPD, The criteria for acute exacerbation of COPD are defined according to the 2023 GOLD guidelines. 2) Individuals aged 40 and above and have signed a written informed consent. 3) After assessing the risk of bleeding, patients with high bleeding risk were evaluated using the internal medicine patient bleeding risk assessment scale recommended in the 2018 Guidelines for the Diagnosis, Treatment, and Prevention of Pulmonary Thromboembolism.
Exclusion criteria
Exclusion criteria: 1) Patients diagnosed or suspected of VTE (including pulmonary embolism and deep vein thrombosis) upon admission; 2) The patient has recently (within one week) used or is currently using anticoagulant or antiplatelet drugs; 3) Active bleeding patients
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| coagulation function indicators (e.g., D-Dimer);TCM syndrome; | — |
Primary
| Measure | Time frame |
|---|---|
| incidence of pulmonary embolism;incidence of deep venous thrombosis; | — |
Countries
China
Contacts
Public ContactQun Yi
Sichuan Cancer Hospital & Institute Sichuan Cancer Center School of Medicine University of Electronic Science and Technology of China
Outcome results
None listed